HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTC: PWRM, www.Power3Medical.com), a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for neurodegenerative disease and breast cancer, announced today that it has received a certification to begin offering CLIA-compliant high complexity medical testing services.
